HighVista Strategies’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
HighVista Strategies's BIIB Position: Q2 2023 in Review
HighVista Strategies sold out of Biogen (BIIB) in Q2 2023, closing a stake of 2,743 shares — an estimated $763K sold.
HighVista Strategies first reported a position in BIIB in Q2 2016 and held it in 17 quarters. The position peaked at $15.3M in Q3 2016. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.
- HighVista Strategies reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
- HighVista Strategies sold 2,743 Biogen shares in Q2 2023, an estimated $763K.
- HighVista Strategies first reported a position in Biogen in Q2 2016 and held it in 17 quarters.
- HighVista Strategies's Biogen position peaked at $15.3M in Q3 2016.
- 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.
Based on HighVista Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.